V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220005799 | 220002259 | 1.84 | null | Curative (C) | 2015-04-27 | 2015-05-02 | FLAG + Idarubicin | Y | N | 220028973 | FLAG + IDARUBICIN |
| 220005800 | 220002260 | 1.62 | 73 | Curative (C) | 2014-06-06 | 2014-06-06 | AML 19 TRIAL | Y | N | 220028981 | AML19 TRIAL |
| 220005801 | 220002260 | 0 | null | null | 2013-12-07 | 2013-12-07 | Nilotinib | 2 | N | 220028981 | NILOTINIB |
| 220005802 | 220002261 | 1.7 | null | Curative (C) | 2014-03-17 | 2014-03-17 | FLAG + Idarubicin | 02 | N | 220028986 | FLAG + IDARUBICIN |
| 220005803 | 220002261 | 0 | null | Disease modification (D) | 2018-06-17 | 2018-06-30 | Nilotinib | N | N | 220028986 | NILOTINIB |
| 220005804 | 220002261 | 1.75 | null | null | 2014-11-08 | 2014-11-15 | Nilotinib | N | N | 220028986 | NILOTINIB |
| 220005805 | 220002262 | 1.85 | 0 | Curative (C) | 2016-02-04 | 2016-02-04 | Nilotinib | N | N | 220028994 | NILOTINIB |
| 220005806 | 220002262 | 1.64 | 70.7 | null | 2015-03-19 | 2015-03-25 | AML Interim Guidelines FLAG-Ida | N | N | 220028994 | FLAG + IDARUBICIN |
| 220005807 | 220002262 | null | null | Curative (C) | 2017-11-15 | 2017-11-19 | AML Interim Guidelines | 1 | N | 220028994 | NOT MATCHED |
| 220005808 | 220002263 | 1.8 | 68 | Curative (C) | 2017-02-03 | 2017-02-12 | FLAG + Idarubicin | 99 | N | 220029000 | FLAG + IDARUBICIN |
| 220005810 | 220002265 | 0 | 0 | Palliative (P) | 2018-04-29 | 2018-04-29 | Nilotinib | 02 | N | 220029004 | NILOTINIB |
| 220005811 | 220002265 | 1.75 | 77.6 | Curative (C) | 2013-12-06 | 2013-12-07 | AML 19 TRIAL | Y | N | 220029004 | AML19 TRIAL |
| 220005812 | 220002265 | 1.66 | null | Palliative (P) | 2014-11-04 | 2014-11-18 | Nilotinib | N | N | 220029004 | NILOTINIB |
| 220005813 | 220002266 | 1.58 | 78.9 | Curative (C) | 2015-01-16 | 2015-01-25 | AML 19 TRIAL | Y | N | 220029010 | AML19 TRIAL |
| 220005814 | 220002267 | 1.68 | null | Curative (C) | 2017-11-03 | 2017-11-11 | AML MyeChild 01 B Cytarabine/Daunoxome + GO | N | N | 220029012 | NOT MATCHED |
| 220005816 | 220002268 | null | null | Palliative (P) | 2013-02-07 | 2013-06-13 | Nilotinib | 2 | N | 220029019 | NILOTINIB |
| 220005817 | 220002268 | 1.64 | null | Curative (C) | 2015-07-06 | 2015-07-09 | AML 19 TRIAL | N | N | 220029019 | AML19 TRIAL |
| 220005818 | 220002268 | null | null | Palliative (P) | 2016-12-01 | 2016-12-01 | Nilotinib | 02 | N | 220029019 | NILOTINIB |
| 220005819 | 220002269 | 1.63 | 56.5 | Curative (C) | null | 2016-12-02 | AML 19 TRIAL | 01 | N | 220029028 | AML19 TRIAL |
| 220005820 | 220002269 | null | 86.5 | Palliative (P) | 2014-06-12 | 2014-06-12 | Nilotinib | 2 | N | 220029028 | NILOTINIB |
| 220005821 | 220002269 | null | null | Palliative (P) | 2017-12-07 | 2017-12-08 | Nilotinib | N | N | 220029028 | NILOTINIB |
| 220005822 | 220002269 | 1.73 | 53 | Curative (C) | 2014-04-09 | 2014-04-13 | AML 19 TRIAL | Y | N | 220029028 | AML19 TRIAL |
| 220005823 | 220002270 | 1.79 | 62 | Curative (C) | 2015-08-27 | 2015-08-27 | FLAG + Idarubicin | 02 | null | 220029037 | FLAG + IDARUBICIN |
| 220005824 | 220011258 | 1.08 | 47.9 | Curative (C) | 2015-03-12 | 2015-03-12 | null | N | N | 220029039 | NOT MATCHED |
| 220005825 | 220002271 | 1.71 | null | Curative (C) | 2017-10-18 | 2017-10-18 | AML 19 TRIAL | Y | N | 220029041 | AML19 TRIAL |
| 220005826 | 220002271 | 1.61 | 75 | Curative (C) | 2017-04-18 | 2017-04-18 | AML 19 TRIAL | 01 | N | 220029041 | AML19 TRIAL |
| 220005827 | 220016038 | 1.64 | 88.5 | Curative (C) | 2016-06-16 | 2016-06-16 | FLAG + Idarubicin | N | N | 220029046 | FLAG + IDARUBICIN |
| 220005832 | 220002274 | null | 10 | Curative (C) | 2014-04-04 | 2014-04-04 | null | 02 | N | 220029062 | NOT MATCHED |
| 220005833 | 220002274 | 1.57 | 77.8 | Curative (C) | null | 2016-07-01 | AML 19 TRIAL | 1 | N | 220029062 | AML19 TRIAL |
| 220005835 | 220002276 | null | 0 | Curative (C) | 2015-04-14 | 2015-05-04 | AML Downs AIE | N | N | 220029068 | NOT MATCHED |
| 220005836 | 220002277 | 1.66 | 81.6 | Curative (C) | 2015-02-02 | 2015-02-02 | AML 19 TRIAL | 1 | N | 220029069 | AML19 TRIAL |
| 220005837 | 220011263 | null | null | null | 2016-05-07 | 2016-05-07 | Nilotinib | N | Y | 220029070 | NILOTINIB |
| 220005838 | 220011263 | 1.78 | 53.7 | Curative (C) | 2014-03-23 | 2014-03-27 | AML Interim Guidelines FLAG-Ida | null | null | 220029070 | FLAG + IDARUBICIN |
| 220005839 | 220002278 | null | 61 | Curative (C) | 2015-12-11 | 2015-12-14 | AML 19 TRIAL | Y | null | 220029078 | AML19 TRIAL |
| 220005840 | 220002278 | 0 | 100 | Curative (C) | 2013-12-04 | 2013-12-04 | Nilotinib | N | N | 220029078 | NILOTINIB |
| 220005841 | 220016040 | 0 | null | null | 2017-04-09 | 2017-04-09 | Nilotinib | 2 | N | 220029082 | NILOTINIB |
| 220005842 | 220002279 | 1.56 | null | Curative (C) | 2013-09-27 | 2013-10-01 | Nilotinib | N | N | 220029084 | NILOTINIB |
| 220005843 | 220002279 | 1.61 | 65 | Curative (C) | 2015-10-05 | 2015-10-05 | AML 19 TRIAL | 2 | N | 220029084 | AML19 TRIAL |
| 220005844 | 220002279 | 1.73 | null | Unknown (U) | 2014-10-17 | 2014-10-24 | FLAG + Idarubicin | null | null | 220029084 | FLAG + IDARUBICIN |
| 220005845 | 220002279 | null | 60 | Curative (C) | 2013-11-13 | 2013-11-13 | FLAG + Idarubicin | 02 | N | 220029084 | FLAG + IDARUBICIN |
| 220005846 | 220002279 | 0 | 0 | Disease modification (D) | 2013-05-17 | 2013-05-17 | Nilotinib | N | Y | 220029084 | NILOTINIB |
| 220005847 | 220002280 | 1.88 | 51.5 | Curative (C) | 2013-03-09 | 2013-03-09 | AML 19 TRIAL | Y | N | 220029095 | AML19 TRIAL |
| 220005848 | 220002280 | 1.59 | 100 | Curative (C) | 2014-02-12 | 2014-02-12 | AML 19 TRIAL | Y | N | 220029095 | AML19 TRIAL |
| 220005849 | 220002281 | 1.56 | 54 | Curative (C) | 2014-02-27 | 2014-03-02 | AML 19 TRIAL | Y | N | 220029097 | AML19 TRIAL |
| 220005850 | 220002282 | 1.72 | 0 | Curative (C) | 2018-02-17 | 2018-02-19 | Nilotinib | N | N | 220029098 | NILOTINIB |
| 220005851 | 220002282 | null | 15.3 | Curative (C) | 2014-02-03 | 2014-02-10 | AML Interim Guidelines FLA -Ida | null | null | 220029098 | NOT MATCHED |
| 220005852 | 220002283 | 1.78 | 72 | Curative (C) | 2013-04-20 | 2013-04-20 | FLAG + Idarubicin | 2 | N | 220029103 | FLAG + IDARUBICIN |
| 220005853 | 220002283 | 1.62 | null | Curative (C) | 2017-09-28 | 2017-09-28 | FLAG + Idarubicin | 2 | N | 220029103 | FLAG + IDARUBICIN |
| 220005854 | 220002283 | 1.79 | 68.2 | Curative (C) | 2016-07-26 | 2016-07-27 | FLAG + Idarubicin | 2 | N | 220029103 | FLAG + IDARUBICIN |
| 220005855 | 220002284 | 1.75 | 107.5 | Curative (C) | 2013-09-25 | 2013-09-25 | AML 19 TRIAL | N | N | 220029110 | AML19 TRIAL |